With Asia Pacific (APAC) set to experience transformative growth, the need to build meaningful connections with microbiome biotechs, pharma voices, government officials, and investment bodies has never been stronger.

For developers of microbiome-based therapeutics, Microbiome Connect: Asia is a unique opportunity to advance your company along its commercialisation journey.

Following its flagship US and EU events, this forum is dedicated to accelerating pipeline development in APAC by showcasing updates from leading biotechs, addressing regional regulatory issues, and promoting collaboration between industry, academia, and service providers.

Join us in the hub of Asian microbiome research to adopt effective manufacturing strategies to achieve commercial scale, build collaborative relationships with regulatory bodies, and address current challenges associated with GMP production in Korea and beyond.

Microbiome Connect: Asia is uniting microbiome industry leaders in APAC to facilitate the development of optimised microbial therapeutics for clinical and commercial success, in Seoul, South Korea on 17th and 18th May 2023.

Click here for more details